Copyright Reports & Markets. All rights reserved.

Global Melatonin API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Melatonin API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Natural
    • 1.3.3 Synthetic
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Melatonin API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Biotechnology Company
    • 1.4.3 Pharmaceutical Company
    • 1.4.4 Others
  • 1.5 Global Melatonin API Market Size & Forecast
    • 1.5.1 Global Melatonin API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Melatonin API Sales Quantity (2021-2032)
    • 1.5.3 Global Melatonin API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck KGaA
    • 2.1.1 Merck KGaA Details
    • 2.1.2 Merck KGaA Major Business
    • 2.1.3 Merck KGaA Melatonin API Product and Services
    • 2.1.4 Merck KGaA Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck KGaA Recent Developments/Updates
  • 2.2 Caesar & Loretz GmbH
    • 2.2.1 Caesar & Loretz GmbH Details
    • 2.2.2 Caesar & Loretz GmbH Major Business
    • 2.2.3 Caesar & Loretz GmbH Melatonin API Product and Services
    • 2.2.4 Caesar & Loretz GmbH Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Caesar & Loretz GmbH Recent Developments/Updates
  • 2.3 EVONIK
    • 2.3.1 EVONIK Details
    • 2.3.2 EVONIK Major Business
    • 2.3.3 EVONIK Melatonin API Product and Services
    • 2.3.4 EVONIK Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 EVONIK Recent Developments/Updates
  • 2.4 Bio-Techne Corp.
    • 2.4.1 Bio-Techne Corp. Details
    • 2.4.2 Bio-Techne Corp. Major Business
    • 2.4.3 Bio-Techne Corp. Melatonin API Product and Services
    • 2.4.4 Bio-Techne Corp. Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Bio-Techne Corp. Recent Developments/Updates
  • 2.5 Cayman Chemical Company (Matreya)
    • 2.5.1 Cayman Chemical Company (Matreya) Details
    • 2.5.2 Cayman Chemical Company (Matreya) Major Business
    • 2.5.3 Cayman Chemical Company (Matreya) Melatonin API Product and Services
    • 2.5.4 Cayman Chemical Company (Matreya) Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Cayman Chemical Company (Matreya) Recent Developments/Updates
  • 2.6 Spectrum Chemical
    • 2.6.1 Spectrum Chemical Details
    • 2.6.2 Spectrum Chemical Major Business
    • 2.6.3 Spectrum Chemical Melatonin API Product and Services
    • 2.6.4 Spectrum Chemical Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Spectrum Chemical Recent Developments/Updates
  • 2.7 Caesar & Loretz GmbH
    • 2.7.1 Caesar & Loretz GmbH Details
    • 2.7.2 Caesar & Loretz GmbH Major Business
    • 2.7.3 Caesar & Loretz GmbH Melatonin API Product and Services
    • 2.7.4 Caesar & Loretz GmbH Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Caesar & Loretz GmbH Recent Developments/Updates
  • 2.8 LGM Pharma
    • 2.8.1 LGM Pharma Details
    • 2.8.2 LGM Pharma Major Business
    • 2.8.3 LGM Pharma Melatonin API Product and Services
    • 2.8.4 LGM Pharma Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 LGM Pharma Recent Developments/Updates
  • 2.9 Flavine Europe GmbH
    • 2.9.1 Flavine Europe GmbH Details
    • 2.9.2 Flavine Europe GmbH Major Business
    • 2.9.3 Flavine Europe GmbH Melatonin API Product and Services
    • 2.9.4 Flavine Europe GmbH Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Flavine Europe GmbH Recent Developments/Updates
  • 2.10 Ralington Pharma
    • 2.10.1 Ralington Pharma Details
    • 2.10.2 Ralington Pharma Major Business
    • 2.10.3 Ralington Pharma Melatonin API Product and Services
    • 2.10.4 Ralington Pharma Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Ralington Pharma Recent Developments/Updates
  • 2.11 SimSon Pharma Limited
    • 2.11.1 SimSon Pharma Limited Details
    • 2.11.2 SimSon Pharma Limited Major Business
    • 2.11.3 SimSon Pharma Limited Melatonin API Product and Services
    • 2.11.4 SimSon Pharma Limited Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 SimSon Pharma Limited Recent Developments/Updates
  • 2.12 Santa Cruz Biotechnology, Inc.
    • 2.12.1 Santa Cruz Biotechnology, Inc. Details
    • 2.12.2 Santa Cruz Biotechnology, Inc. Major Business
    • 2.12.3 Santa Cruz Biotechnology, Inc. Melatonin API Product and Services
    • 2.12.4 Santa Cruz Biotechnology, Inc. Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Santa Cruz Biotechnology, Inc. Recent Developments/Updates
  • 2.13 Biosynth
    • 2.13.1 Biosynth Details
    • 2.13.2 Biosynth Major Business
    • 2.13.3 Biosynth Melatonin API Product and Services
    • 2.13.4 Biosynth Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Biosynth Recent Developments/Updates
  • 2.14 Otto Chemie Pvt. Ltd.
    • 2.14.1 Otto Chemie Pvt. Ltd. Details
    • 2.14.2 Otto Chemie Pvt. Ltd. Major Business
    • 2.14.3 Otto Chemie Pvt. Ltd. Melatonin API Product and Services
    • 2.14.4 Otto Chemie Pvt. Ltd. Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Otto Chemie Pvt. Ltd. Recent Developments/Updates
  • 2.15 Pharmaffiliates Analytics and Synthetics P. Ltd.
    • 2.15.1 Pharmaffiliates Analytics and Synthetics P. Ltd. Details
    • 2.15.2 Pharmaffiliates Analytics and Synthetics P. Ltd. Major Business
    • 2.15.3 Pharmaffiliates Analytics and Synthetics P. Ltd. Melatonin API Product and Services
    • 2.15.4 Pharmaffiliates Analytics and Synthetics P. Ltd. Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Pharmaffiliates Analytics and Synthetics P. Ltd. Recent Developments/Updates
  • 2.16 Clearsynth Labs
    • 2.16.1 Clearsynth Labs Details
    • 2.16.2 Clearsynth Labs Major Business
    • 2.16.3 Clearsynth Labs Melatonin API Product and Services
    • 2.16.4 Clearsynth Labs Melatonin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Clearsynth Labs Recent Developments/Updates

3 Competitive Environment: Melatonin API by Manufacturer

  • 3.1 Global Melatonin API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Melatonin API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Melatonin API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Melatonin API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Melatonin API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Melatonin API Manufacturer Market Share in 2025
  • 3.5 Melatonin API Market: Overall Company Footprint Analysis
    • 3.5.1 Melatonin API Market: Region Footprint
    • 3.5.2 Melatonin API Market: Company Product Type Footprint
    • 3.5.3 Melatonin API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Melatonin API Market Size by Region
    • 4.1.1 Global Melatonin API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Melatonin API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Melatonin API Average Price by Region (2021-2032)
  • 4.2 North America Melatonin API Consumption Value (2021-2032)
  • 4.3 Europe Melatonin API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Melatonin API Consumption Value (2021-2032)
  • 4.5 South America Melatonin API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Melatonin API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Melatonin API Sales Quantity by Type (2021-2032)
  • 5.2 Global Melatonin API Consumption Value by Type (2021-2032)
  • 5.3 Global Melatonin API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Melatonin API Sales Quantity by Application (2021-2032)
  • 6.2 Global Melatonin API Consumption Value by Application (2021-2032)
  • 6.3 Global Melatonin API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Melatonin API Sales Quantity by Type (2021-2032)
  • 7.2 North America Melatonin API Sales Quantity by Application (2021-2032)
  • 7.3 North America Melatonin API Market Size by Country
    • 7.3.1 North America Melatonin API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Melatonin API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Melatonin API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Melatonin API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Melatonin API Market Size by Country
    • 8.3.1 Europe Melatonin API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Melatonin API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Melatonin API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Melatonin API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Melatonin API Market Size by Region
    • 9.3.1 Asia-Pacific Melatonin API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Melatonin API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Melatonin API Sales Quantity by Type (2021-2032)
  • 10.2 South America Melatonin API Sales Quantity by Application (2021-2032)
  • 10.3 South America Melatonin API Market Size by Country
    • 10.3.1 South America Melatonin API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Melatonin API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Melatonin API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Melatonin API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Melatonin API Market Size by Country
    • 11.3.1 Middle East & Africa Melatonin API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Melatonin API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Melatonin API Market Drivers
  • 12.2 Melatonin API Market Restraints
  • 12.3 Melatonin API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Melatonin API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Melatonin API
  • 13.3 Melatonin API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Melatonin API Typical Distributors
  • 14.3 Melatonin API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Melatonin API market size was valued at US$ 117 million in 2025 and is forecast to a readjusted size of US$ 199 million by 2032 with a CAGR of 8.0% during review period.
    The term "API" in the context of pharmaceuticals stands for Active Pharmaceutical Ingredient. An Active Pharmaceutical Ingredient is the biologically active component of a drug, and it is responsible for its therapeutic effects. Melatonin is a hormone naturally produced in the pineal gland of the brain, and it plays a crucial role in regulating the sleep-wake cycle. When used in the context of pharmaceuticals, "Melatonin API" refers to the active pharmaceutical ingredient of melatonin that is isolated and used as the primary therapeutic agent in medications.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Melatonin API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Melatonin API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Melatonin API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Melatonin API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Melatonin API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Melatonin API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Melatonin API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Caesar & Loretz GmbH, EVONIK, Bio-Techne Corp., Cayman Chemical Company (Matreya), Spectrum Chemical, Caesar & Loretz GmbH, LGM Pharma, Flavine Europe GmbH, Ralington Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Melatonin API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Natural
    Synthetic
    Market segment by Application
    Biotechnology Company
    Pharmaceutical Company
    Others
    Major players covered
    Merck KGaA
    Caesar & Loretz GmbH
    EVONIK
    Bio-Techne Corp.
    Cayman Chemical Company (Matreya)
    Spectrum Chemical
    Caesar & Loretz GmbH
    LGM Pharma
    Flavine Europe GmbH
    Ralington Pharma
    SimSon Pharma Limited
    Santa Cruz Biotechnology, Inc.
    Biosynth
    Otto Chemie Pvt. Ltd.
    Pharmaffiliates Analytics and Synthetics P. Ltd.
    Clearsynth Labs
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Melatonin API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Melatonin API, with price, sales quantity, revenue, and global market share of Melatonin API from 2021 to 2026.
    Chapter 3, the Melatonin API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Melatonin API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Melatonin API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Melatonin API.
    Chapter 14 and 15, to describe Melatonin API sales channel, distributors, customers, research findings and conclusion.

    Buy now